Primitiv Group

Primitiv Group is a healthcare and wellness startup founded in 2022. The company's mission is to be a guiding force in the cannabis industry by advocating for holistic relief for patients dealing with chronic illness and pain, while also raising awareness about the health benefits of marijuana. Through strategic partnerships with esteemed institutions such as the International Phytomedicines and Medical Cannabis Institute at Harvard University, Primitiv is dedicated to advancing research and disseminating information about the therapeutic properties of cannabis for a wide array of medical conditions, including chronic pain, CTE (chronic traumatic encephalopathy), and cancer treatments. The company is committed to uncovering the vast potential of this plant as a healing agent and is actively engaged in conducting research and gathering data to support the development of reliable and effective treatment options in the market.